Page 814 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

770 INDEX INDEX

Furosemide, 252, 608 Gangrenous necrosis, 209 Gastroschisis, 358 Germ cell tumors
gout with, 250 Gap junctions, 474 Gastrosplenic ligament, 361 cryptorchidism risk for, 651
pancreatitis, 249 Gardener’s pupil, 241 Gastrulation, 612 hormone levels in, 653
Fusion inhibitors, 203 Gardnerella vaginalis, 148 Gaucher disease, 88 testicular, 652
Fusion protein EWS-FLI1, 465 Gardner syndrome, 387 osteonecrosis, 463 Germinal centers of lymph nodes, 96
Fusobacterium spp Gargoylism, 88 osteonecrosis in, 463 Germinal center (spleen), 98
alcoholism, 179 Gas gangrene Gaussian distribution, 262 Gerstmann syndrome, 511
anaerobic metabolism of, 127 alpha toxin, 133 G cells, 371 Gestational age calculation, 633
Clostridium perfringens, 138, 179 Gemfibrozil, 320 Gestational diabetes, 634
G Gastrectomy, 420 Gemifloxacin, 195 Gestational hypertension, 643
G6PD Gastric acid, 372 Gender dysphoria, 567 GFAP (glial fibrillary acid proteins),
deficiency, 61, 79 histamine receptors and, 238 Gender identity, 635 48, 227
HMP shunt and, 73 regulatory substances and, 371 Gene expression astrocyte marker, 493
in respiratory burst, 109 Gastric arteries modifications, 56 cytoskeletal elements, 48
G6PD deficiency, 422 celiac trunk, 364 regulation, 41 stain, 227
GABA intraligmental, 361 Generalized anxiety disorder (GAD), Ghrelin, 336, 371
anesthesia effects, 550 Gastric bypass surgery 563 Giant cells
barbiturate effects, 546 ghrelin and, 371 buspirone, 574 with Aschoff bodies, 312
basal ganglia and, 500 vitamin B deficiency, 69 drug therapy for, 572 astrocytomas, 525
12
benzodiazepine effects, 546 Gastric cancer, 379 Selective serotonin reuptake Warthin-Finkeldey, 170
changes with disease, 495 carcinogens causing, 225 inhibitors (SSRIs) for, 575 Giant cell (temporal) arteritis, 314,
epilepsy drugs, 544 Helicobacter pylori, 146 serotonin-norepinephrine reuptake 518
Huntington disease, 520 oncogenes and, 224 inhibitors (SNRIs) for, 575 polymyalgia rheumatica, 470
vitamin B and, 67 oncogenic microbes and, 226 Generalized seizures, 517 Giant cell tumor, 464
6
Gabapentin, 544 sign of Leser-Trélat and, 228 Genes Giardia spp
GABA receptor agonists, 523, 551 trastuzumab for, 443 introns vs exons, 42, 43 fluorescent antibody stain, 125
B
gag gene, 175 types of, 379 Genetics, 56–65 watery diarrhea, 179
Gag reflex, 507 Gastric inhibitory peptide (GIP), anticipation, 62 Giardia lamblia, 155
Gait disorders 351 autosomal dominant diseases, 60 Giardiasis, 155
“steppage,” 453 Gastric outlet obstruction, 359, autosomal recessive diseases, 60 Giemsa stain, 125
Trendelenburg sign/gait, 453 380 autosomal trisomies, 63 Borrelia, 146
Gait disturbance Gastric sclerosis, 473 bacterial, 130–204, 131 chlamydiae, 148
cerebellar lesions and, 499 Gastric ulcers, 380 chromosome disorders, 64 Gigantism, 329, 339
Friedreich ataxia, 531 NSAID toxicity, 486 code features, 37 Gilbert syndrome, 393, 394
Parkinson disease, 520 Gastric vessels, 361 inheritance modes, 59 Gingival hyperplasia
vitamin B deficiency, 530 Gastrin, 371, 373 muscular dystrophies, 61 calcium channel blockers, 318
12
waddling, 61 signaling pathways for, 337 terms, 56–57 cyclosporine, 120
Galactocerebrosidase, 88 somatostatinomas and, 351 trinucleotide repeat expansion drug reaction and, 250
Galactocerebroside, 88 Gastrinomas, 354, 371 diseases, 62 Gingivostomatitis, 164
Galactokinase deficiency, 80 Gastrin-releasing peptide (GRP), 371 viral, 162–163 Gitelman syndrome, 586
cataracts and, 535 Gastritis, 146, 379 X-linked recessive disorders, 61 markers in, 591
Galactorrhea gastrin in, 371 Geniculate nuclei (thalamus), 498 Glans penis
antipsychotic drugs and, 328 H blockers for, 399 Genital herpes, 184 lymphatic drainage of, 624
2
pituitary prolactinomas, 328 proton pump inhibitors for, 399 Genitalia Glanzmann thrombasthenia, 427
tuberoinfundibular pathway, stomach cancer and, 379 ambiguous, 622, 638, 639 Glaucoma, 242
499 Gastrocolic ligament, 361 embryology of, 612, 622 atropine, 241
Galactose-1-phosphate Gastroenteritis estrogen and, 630 β-blockers for, 245
uridyltransferase, 80 caliciviruses, 167 male/female homologs, 623 carbachol for, 240
Galactose metabolism Listeria monocytogenes, 139 Genital tubercles, 624 closed-angle, 240
disorders of, 80 rotavirus, 168 Genital ulcers, 184 diabetes mellitus and, 346
Galactosemia, 80 Salmonella spp, 144 Genital warts, 184 diagnosis of, 240
cataracts and, 535 Gastroepiploic arteries, 361, 364 Genitofemoral nerve, 452 epinephrine for, 242
Galantamine, 240, 549 Gastroesophageal reflux disease Genitourinary/renal drug reactions, open-angle, 240, 242
Galant reflex, 510 (GERD) 251 pilocarpine for, 240
Gallbladder Barrett esophagus, 378 Genome editing types of, 536
biliary structures, 368 esophageal cancer and, 378 reverse transcriptase polymerase Glioblastoma multiforme, 526
blood supply and innervation of, presentation, 377 chain reaction, 52 nitrosoureas for, 441
364 Gastrohepatic ligament, 361 Genotyping microarrays, 54 Glipizide, 353
regulatory substances, 371 Gastrointestinal bleeding Gentamicin, 191 Glitazones/thiazolidinediones, 353
Gallbladder cancer hereditary hemorrhagic Genu varum (bow legs), 463 Global aphasia, 516
porcelain gallbladder and, 397 telangiectasia, 316 Geriatric patients Global payment, 271
sclerosing cholangitis and, 395 Gastrointestinal drug reactions, 249 atropine in, 241 Globoid cells
Gallstone ileus, 396 Gastrointestinal stromal tumors Beers criteria in, 247 Krabbe disease, 88
γ-glutamyltransferase (GGT) (GISTs), 224 changes in, 270 Globose nucleus, 499
alcohol use, 570 Gastrointestinal system colonic ischemia and, 386 Globus pallidus externus, 500
γ-glutamyl transpeptidase (GGT), anatomy, 360–369 colorectal cancer, 388 Glomerular disorders/disease
390 blood supply to, 363 common cause of death, 272 etiology and presentation, 594
γ-interferon, 407 embryology, 358–359 drug-related delirium in, 558, 575 nomenclature, 594
Ganciclovir, 202 innervation of, 364 lipofuscin in, 211 types of, 595
agranulocytosis, 250 ligaments, 361 Medicare for, 272 Glomerular filtration barrier, 581
Ganglion cyst, 461 pathology, 376–397 nosocomial infections, 185 Glomerular filtration parameters,
Ganglioneuromatosis pharmacology, 398–400 osteoporosis, 462 583
oral/intestinal, 351 physiology, 371–375 PPI adverse effects, 399 Glomerular filtration rate (GFR), 582
Gangrene regulatory substances, 371 respiratory system changes in, 665 ACE inhibitor effects, 610
Buerger disease, 314 secretory cells, 373 vascular skin tumors, 478 glomerular dynamics in, 583
diabetes mellitus, 346 secretory products, 372 Zenker diverticulum, 384 juxtaglomerular apparatus, 589

FAS1_2019_21_Index_749-806.indd 770 11/21/19 12:27 PM